LEO 32731 - A Phase I Drug-Drug Interaction Study With LEO 32731 and Midazolam in Healthy Male Subjects

Trial Profile

LEO 32731 - A Phase I Drug-Drug Interaction Study With LEO 32731 and Midazolam in Healthy Male Subjects

Discontinued
Phase of Trial: Phase I

Latest Information Update: 05 May 2017

At a glance

  • Drugs LEO 32731 (Primary) ; Midazolam
  • Indications Atopic dermatitis; Psoriasis
  • Focus Pharmacokinetics
  • Sponsors LEO Pharma
  • Most Recent Events

    • 16 Aug 2016 Status changed from completed to discontinued.
    • 16 Jun 2016 Status changed from recruiting to completed.
    • 29 Apr 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top